期刊文献+

58型人乳头瘤病毒L2蛋白的原核表达、纯化及单克隆抗体的制备 被引量:2

Prokaryotic Expression and Purification of Minor Capsid Protein L2 Derived from Human Papillomavirus 58 and Preparation of Monoclonal Antibody
原文传递
导出
摘要 目的原核表达并纯化我国高发的致宫颈癌58型人乳头瘤病毒(Human papillomavirus,HPV)次要衣壳蛋白L2,并制备其单克隆抗体。方法从含有HPV-58基因组的质粒pHPV58中扩增L2基因,插入改构的原核表达载体pGEX-KGV中,转化大肠杆菌BL21(DE3),乳糖诱导表达,透析复性并亲和层析纯化重组蛋白,采用杂交瘤技术制备单克隆抗体,并对其进行鉴定。结果重组表达质粒pGEX-KGV-HPV58 L2经双酶切和测序证明构建正确;表达的重组蛋白主要以包涵体形式存在,表达量可占菌体总蛋白的15.5%;纯化的重组蛋白纯度可达95%;共获得10株抗HPV-58 L2的高效价单克隆抗体。结论已成功原核表达、纯化了HPV-58 L2重组蛋白,并制备了单克隆抗体,为下一步HPV-58 L2蛋白抗原表位的研究以及相关预防性抗体药物和广谱重组疫苗的开发奠定了基础。 Objective To express the minor capsid protein L2 derived from human papillomavirus(HPV) 58 which caused majority of cervical cancer in China in prokaryotic cells,purify the expressed product and prepare its monoclonal antibody(McAb).Methods L2 gene was amplified from plasmid pHPV58 containing the genome of HPV-58 and inserted into modified prokaryotic expression vector pGEX-KGV.The constructed recombinant plasmid pGEX-KGV-HPV58 L2 was transformed to E.coli BL21(DE3) for expression under induction of lactose.The expressed protein was re-naturalized by dialysis and purified by affinity chromatography,based on which McAb was prepared by hybridoma technique and identified.Results Restriction analysis and sequencing proved that recombinant plasmid pGEX-KGV-HPV58 L2 was constructed correctly.The expressed protein,mainly existing in a form of inclusion body,contained 15.5% of total somatic protein and reached a purity of 95% after purification.A total of cell strains secreting high titer McAbs were obtained.Conclusion HPV-58 L2 protein was successfully expressed in prokaryotic cells and purified,and its McAb was prepared,which laid a foundation of further study on the antigenic epitope of L2 protein as well as development of relevant prophylactic antibody drug and broad spectrum recombinant vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第4期398-403,共6页 Chinese Journal of Biologicals
关键词 58型人乳头瘤病毒 L2蛋白 原核细胞 基因表达 蛋白质复性 抗体 单克隆 Human papillomavirus(HPV) 58 L2 protein Prokaryotic cells Gene expression Protein renaturation Antibody monoclonal
  • 相关文献

参考文献15

  • 1Parkin DM, Bray F, Ferlay J, et al Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55 (2): 74-108. 被引量:1
  • 2De Villlers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses [J]. Virology, 2004, 324 ( 1 ) : 17-27. 被引量:1
  • 3Stanley M. Immunobiology of HPV and HPV vaccines [J]. Gynecol Oncol, 2008, 109 (2 Suppl): S15-S21. 被引量:1
  • 4刘静,糜若然.人乳头瘤病毒防治疫苗的应用研究进展[J].实用妇产科杂志,2010,26(1):17-20. 被引量:5
  • 5Lin K, Doolan K, Hung CF, et al. Perspectives for preventive and therapeutic HPV vaccines [J]. J Formos Med Assoe, 2010, 109 (1): 4-24. 被引量:1
  • 6Kondo K, Ishii Y, Ochi H, et al. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region [J]. Virology, 2007, 358 (2): 266-272. 被引量:1
  • 7Buck CB, Cheug N, Thompson CD, et al. Arrangement of L2 within the papillomavirus capsid [J]. J Virol, 2008, 82 (11): 5190-5197. 被引量:1
  • 8Malboeuf CM, Simon DAL, Lee YE, et al. Human papillo- mavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo [J ]. Vaccine, 2007, 25 (17): 3270-3276. 被引量:1
  • 9Pereira R, Hitzeroth II, Rybicki EP. Insights into the role and function of L2, the minor capsid protein of papillomaviruses [J]. Arch Virol, 2009, 154 (2): 187-197. 被引量:1
  • 10Knappe M, Bodevin S, Selinka HC, et ol. Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate [J]. J Biol Chem, 2007, 282 (38) : 27913-27922. 被引量:1

二级参考文献20

  • 1Tay SK, Ngan HY, Chu TY, et al. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan [J]. Vaccine, 2008,26(12) :60-70. 被引量:1
  • 2Giuliano AR, Tortolero-Luna G, Ferrer E, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions [ J ]. Vaccine, 2008,26 ( 10 ) : 17 - 28. 被引量:1
  • 3Kocjan B./, Seine K, Poljak M. Detection and differentiation of human papillomavirus genotypes HPV-6 and HPV-11 by FRET-based real-time PCR [J]. J Virol Methods, 2008,153(2) :245 -249. 被引量:1
  • 4Kang YH, Lee KA, Ryu C J, et al. Mitomycin einduees apoptosis via Fas/FasL dependant pathway and suppression of IL-18 in cervical carcinoma cells [J]. Cancer Lett, 2006,237( 1 ) :33 -34. 被引量:1
  • 5Reuschenbach M, Waterboer T, Wallin KL, et al. Characterization of humoral immune responses against P16, P53, HPV16 E6 and HPV16 E7 in patients with PHV-associated cancers [ J]. Int J Cancer, 2008, 123 ( 11 ) :2626 - 2631. 被引量:1
  • 6Rosenthal SL, Rupp R,Zimet GD,et al. Uptake of HPV vaccine:demographics, sexual history and values, parenting style, and vaccine attitudes [J]. J Adolesc Health,2008,43 (3) :239 -245. 被引量:1
  • 7Myers E, Huh Wk, Wright JD, et al. The current and future role of screening in the era of HPV vaccination [ J]. Gynecol Oncol, 2008, 109(2) :31 -39. 被引量:1
  • 8Kanda T, Kondo K. Development of an HPV vaccine for abroad spectrum of high-risk types [ J]. Hum Vaccin, 2008,5 ( 1 ) :38 -42. 被引量:1
  • 9Bayas JM, Costas L, Munoz A. Cervical cancer vaccination indications, efficacy, and side effects [ J]. Gynecol Oncol, 2008,110 (3) : 11 -14. 被引量:1
  • 10Govan VA. A novel vaccine for cervical cancer: quadrivalent human papilloma virus( types 6,11, 16 and 18 ) recombinant vaccine( gardasil) [J]. Ther Clin Risk Manag, 2008,4( 1 ) :65 -70. 被引量:1

共引文献4

同被引文献24

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部